2007-47-eec - rev mdd
TRANSCRIPT
![Page 1: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/1.jpg)
2007/47/EC
Amending 90/385/EEC (AIMD), 93/42/EEC (MDD) & 98/8/EC (Biocidal Products)
![Page 2: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/2.jpg)
Contents of Presentation
Structure of the New Directive Overview of Revision Impact on Manufacturers Other Changes Summary
![Page 3: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/3.jpg)
Structure of Directive
![Page 4: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/4.jpg)
2007/47/EC - Contents
Whereas : Reasons for changes Article 1 : Changes to 90/385/EEC (AIMD) Article 2 : Changes to 93/42/EEC (MDD) Article 3 : Addition to 98/8/EC (biocidal) Article 4 : Adoption 21-Mar-10 Article 5 : Into force (20th day after OJ) Article 6 : Addressed to Member States
![Page 5: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/5.jpg)
2007/47/EC - Annexes
Annex I amends 90/385/EC Annexes 1-7 Annex II amends 93/42/EEC Annexes I-X
![Page 6: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/6.jpg)
Overview of Revisions
![Page 7: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/7.jpg)
Purpose of Revision
Better specify obligations of key players Manufacturers, Notified Bodies & Authorities
Ensure highest level of safety
Support the legal framework Transparency
EU part of global activities on regulatory convergence – GHTF
![Page 8: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/8.jpg)
Emphasis on Key Issues
Clinical Evaluation
Conformity Assessment
Post Market Surveillance
![Page 9: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/9.jpg)
Definitions
Medical Device (Revised) software specifically for diagnosis &/or therapeutic
purposes Clinical Data – (New)
IMPORTANT, see also Article 15 & Annex X Additional New Definitions
Device subcategory Generic device group Single use device
![Page 10: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/10.jpg)
Implementation Timelines
Publication Transposition by Member
States Implementation EU Databank (eudamed)
Other: MedDev 2.12/2 Vigilance
Sept. 2007 By Dec. 2008
From Mar. 2010 5 Sep. 2012
Jan. 2008
![Page 11: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/11.jpg)
MDD Changes
More of a clarification on many issues Some significant changes
Whole area of Clinical EvaluationPost-Market SurveillanceReclassification of some DevicesTransparency & Co-operation
![Page 12: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/12.jpg)
Impact on Manufacturers
![Page 13: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/13.jpg)
Impact for ManufacturersANALYSIS of PRODUCT
and its FEATURES
IDENTIFY APPLICABLEESSENTIAL REQUIREMENTS
CLASSIFICATIONof PRODUCTS
CONFORMITY to E.R.:STANDARDS, OTHER
TECHNICAL DOCUMENTATIONCONFORMITYASSESSMENT
CHOICE of CONFORMITYASSESSMENT ROUTE
00500050
Is my product a MEDICAL DEVICE?
What CLASS is my device?
What do I do to put CE on my device?How do I show conformity of my device?
Which Requirements apply to my device?
![Page 14: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/14.jpg)
Is my Product a Medical Device?
Definition of Medical Device
Demarcation – other directives
Changes?
![Page 15: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/15.jpg)
Medical Device Definition
any instrument, apparatus, appliance, software, material or other article, whether used alone or in combination, including the software intended by its manufacturer to be used specifically for diagnostic and/or therapeutic purposes and necessary for its proper application, intended by the manufacturer to be used for human beings for the purpose of ….. (Article 1. 2(a))
![Page 16: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/16.jpg)
Scope of Directive
Device can be both MDD & PPE (Article 1. 6)
Drug/Device?Principle Mode of action taken into account.
(Article 1 5(c)) PHYSICAL action = Device PHARMACOLOGICAL action = Drug
MEDDEV 2.1/3 rev2http://ec.europa.eu/enterprise/medical_devices/meddev/2_1_3____07-2001.pdf
![Page 17: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/17.jpg)
Impact for ManufacturersANALYSIS of PRODUCT
and its FEATURES
IDENTIFY APPLICABLEESSENTIAL REQUIREMENTS
CLASSIFICATIONof PRODUCTS
CONFORMITY to E.R.:STANDARDS, OTHER
TECHNICAL DOCUMENTATIONCONFORMITYASSESSMENT
CHOICE of CONFORMITYASSESSMENT ROUTE
Is my product a MEDICAL DEVICE?
What CLASS is my device?
What do I do to put CE on my device?How do I show conformity of my device?
Which Requirements apply to my device?
![Page 18: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/18.jpg)
What Class is my Product?
Classification Rules – Annex IX
Changes?
![Page 19: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/19.jpg)
Classification Rules
Software – considered ‘Active Device’ (Annex IX 1.4)
(Rules 9 – 12 apply) Central Circulatory System – Extended (Annex IX 1.7)
arcus aorta & aorta descendens to the bifurcatio aortae now included – CCS : Class III
Duration of use – May be extended (Annex IX 2.6)
If device discontinued and replaced immediately by the same/identical device, consider as extension
![Page 20: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/20.jpg)
Classification Rules (cont.)
Rule 5 – Invasive with respect to a body orifice Now includes connection to active device
Rule 6 – Surgically invasive, transient use Now includes contact with CNS : Class III
Rule 15 – Disinfecting/Cleaning/Rinsing If disinfecting invasive devices, now Class IIb
Rule 16 – Recording X-Ray Diagnostic Images removed term “non-active”
![Page 21: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/21.jpg)
Note:
Proposal regarding reusable surgical instruments was NOT adopted.
![Page 22: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/22.jpg)
Impact for ManufacturersANALYSIS of PRODUCT
and its FEATURES
IDENTIFY APPLICABLEESSENTIAL REQUIREMENTS
CLASSIFICATIONof PRODUCTS
CONFORMITY to E.R.:STANDARDS, OTHER
TECHNICAL DOCUMENTATIONCONFORMITYASSESSMENT
CHOICE of CONFORMITYASSESSMENT ROUTE
Is my product a MEDICAL DEVICE?
What CLASS is my device?
What do I do to put CE on my device?How do I show conformity of my device?
Which Requirements apply to my device?
![Page 23: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/23.jpg)
How do I place CE on my device?
Conformity Assessment Routes
Registration
![Page 24: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/24.jpg)
Conformity Assessment Routes
Only 1 Significant Change :Annex II now a Valid Route for Class I Sterile
or with Measuring Function. (Annex VII 5)
![Page 25: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/25.jpg)
Registration
Article 14 – Single Authorized Rep mandatory if manufacturer outside of the EU.
![Page 26: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/26.jpg)
Impact for ManufacturersANALYSIS of PRODUCT
and its FEATURES
IDENTIFY APPLICABLEESSENTIAL REQUIREMENTS
CLASSIFICATIONof PRODUCTS
CONFORMITY to E.R.:STANDARDS, OTHER
TECHNICAL DOCUMENTATIONCONFORMITYASSESSMENT
CHOICE of CONFORMITYASSESSMENT ROUTE
Is my product a MEDICAL DEVICE?
What CLASS is my device?
What do I do to put CE on my device?How do I show conformity of my device?
Which Requirements apply to my device?
![Page 27: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/27.jpg)
Which Requirements Apply to my Device? Changes in Annex I – Essential
Requirements (E.R.)
Relationship with other DirectivesPPE – E.R. from 89/686/EEC (Article 1 (6))
Machinery – E.R. from 2006/42/EC (Article 3)
![Page 28: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/28.jpg)
Essential Requirements changes
1. General (Safety) Requirement – add:This shall include:Reducing, as far as possible, the risk of use
error due to ergonomics/environment used (design for patient safety)
Consideration of technical knowledge, experience, education & training, also medical/physical conditions of intended users (design for lay/professional/disabled or other)
![Page 29: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/29.jpg)
E.R. Changes (cont.)
6a. Demonstration of conformity with the essential requirements must include a clinical evaluation in accordance with Annex X
7.1 Validity of biophysical or modelling research demonstrated beforehand
![Page 30: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/30.jpg)
E.R. Changes (cont.)
7.4 Hazardous SubstancesDirective 2001/83/EC replaces 65/65/EECMedicinal: Notified Body seek opinion from
Competent Authority (CA) or EMEAHuman blood: seek opinion from EMEAChanges made to manufacturing process –
consult with CA to confirm Quality & Safety maintained
![Page 31: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/31.jpg)
E.R. Changes (cont.)
7.5 Substances LeakingSpecial attention to carcinogenic, mutagenic
or toxic to reproduction – Annex I 67/548/EECPhthalates – labeledTreating children/pregnant/nursing women,
specific justification for use & IFU
![Page 32: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/32.jpg)
E.R. Changes (cont.)
12.1a – Software validation (new) 13.3f – Indication of single use must be
consistent across the Community 13.3h – If single use, include why not to
re-use in IFU : if no IFU make available on request
13.6q – Date of issue/rev. on IFU
![Page 33: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/33.jpg)
Impact for ManufacturersANALYSIS of PRODUCT
and its FEATURES
IDENTIFY APPLICABLEESSENTIAL REQUIREMENTS
CLASSIFICATIONof PRODUCTS
CONFORMITY to E.R.:STANDARDS, OTHER
TECHNICAL DOCUMENTATIONCONFORMITYASSESSMENT
CHOICE of CONFORMITYASSESSMENT ROUTE
Is my product a MEDICAL DEVICE?
What CLASS is my device?
What do I do to put CE on my device?How do I show conformity of my device?
Which Requirements apply to my device?
![Page 34: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/34.jpg)
How do I show Conformity?
Changes to Technical Documentation Clinical Evaluation Quality System Requirements
![Page 35: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/35.jpg)
Technical Documentation
Declaration of Conformity Covers one or more medical devices Clearly identified (name, code, unambiguous ref.)
Documentation includes Intended use Statement regarding tissues of animal origin Pre-Clinical & Clinical Evaluation (see Clinical Data!)
Annex VIII Statement more defined(Custom made/for Clinical Investigations)
![Page 36: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/36.jpg)
Clinical Data – New Definition
the safety and/or performance information that is generated from the use of a device. Clinical data are sourced from: clinical investigation (s) of the device concerned; or clinical investigation (s) or other studies reported in the
scientific literature, of a similar device for which equivalence to the device in question can be demonstrated; or
published and/or unpublished reports on other clinical experience of either the device in question or a similar device for which equivalence to the device in question can be demonstrated.
![Page 37: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/37.jpg)
Clinical Evaluation – Annex X
Confirmation of conformity with ER 1 & 3 under normal conditions of use of the device and the evaluation of the side-effects and of the acceptability of the benefit/risk ratio in ER 6 must be based on clinical data.
![Page 38: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/38.jpg)
Clinical Evaluation – Annex X
The evaluation of this data (‘clinical evaluation’) must follow a defined and methodologically sound procedure based on either: a) A critical evaluation of the relevant scientific literature
currently available relating to the safety, performance, design characteristics and intended purpose of the device (demonstration of equivalance of the device and the data adequately demonstrates compliance with the relevant ERs),
b) Or a critical evaluation of the results of all the clinical investigations made,
c) Or a critical evaluation of the combined clinical data in a) & b) above
![Page 39: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/39.jpg)
Clinical Evaluation – Annex X
For implantable & Class III devices, clinical investigations shall be performed unless it is duly justified to rely on existing clinical data.
The clinical evaluation and its documentation must be actively updated with data obtained from the post-market surveillance. Where post-market clinical follow-up (part of the post-market surveillance plan) is not deemed necessary, this must be duly justified and documented.
![Page 40: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/40.jpg)
Clinical Evaluation – Annex X
Where demonstration of conformity with ERs based on clinical data is not deemed appropriate, adequate justification for any such exclusion has to be given based on risk management output and under consideration of the specifics of the device/body interaction, the clinical performances intended and the claims of the manufacturer. Adequacy of demonstration of conformity with the essential requirements by performance evaluation, bench testing and pre-clinical evaluation alone has to be duly substantiated.
![Page 41: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/41.jpg)
Clinical Data
Clinical Evaluation & Outcome Documented Included in Technical Documentation Also references in Annexes II-VII to Post
Market Surveillance including provisions of Annex X
ER 14 replaced by ER 6a – NO exceptions
![Page 42: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/42.jpg)
Clinical Investigation
Review of Clinical Investigation Plan If refused/halted by Member State – they
communicate decision & grounds to all. Manufacturer advises when investigation
ends. If terminated early – justification & communicated to all.
![Page 43: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/43.jpg)
Clinical Investigation (cont.)
Annex VIII – Statement Investigator’s brochure Confirmation of insurance of subjects Documentation to obtain informed consent Statement regarding medicinal/human blood & tissues
of animal origin Annex X – adverse event reporting
ALL serious adverse events, whether device related or not.
![Page 44: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/44.jpg)
Quality System Requirements
Documents & Records to be retained for5 years15 years if Implantable Device
Methods for the control of outsourced processes – design &/or manufacturingMust be documented
![Page 45: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/45.jpg)
Other Changes
![Page 46: 2007-47-EEC - Rev MDD](https://reader035.vdocuments.mx/reader035/viewer/2022062312/5532e34e55034687698b4718/html5/thumbnails/46.jpg)
Thank You